Internal Medicine, Infectious Disease · Louisville, KY
NPI
1184983306
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
501 E Broadway, Suite #380
Louisville, KY, 40202
Phone (502) 852-1147
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
914 services
Medicare patients, 2024
250
Average age 74
Drug cost, 2024
$485K
688 prescriptions
Company payments, 2025
$57K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin L Gnoni was code 99232 (hospital e&m - subsequent), 360 times for 125 patients. In total Martin L Gnoni billed 914 services in 24 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 360 | 125 | $61.23 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 175 | 51 | $92.64 | $16K |
| 99223 Hospital E&M - Initial | Facility | 124 | 115 | $134.39 | $17K |
| 99213 Office E&M - Established | Office | 62 | 48 | $46.77 | $2,900 |
| 99214 Office E&M - Established | Office | 59 | 46 | $71.13 | $4,197 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 26 | $12.52 | $413 |
| 99204 Office E&M - New | Office | 13 | 13 | $100.08 | $1,301 |
| 99222 Hospital E&M - Initial | Facility | 12 | 11 | $99.53 | $1,194 |
By year: 2022 $80K for 1,035 services; 2023 $80K for 1,046 services; 2024 $70K for 914 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martin L Gnoni prescribed most often to Medicare patients was Doxycycline Hyclate, with 47 prescriptions and refills. In total Martin L Gnoni wrote 688 Medicare prescriptions that cost $485K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 47 | 65 | 18 | $2,398 |
| Vancomycin Hcl Generic | 42 | 44 | 17 | $5,698 |
| Minocycline Hcl Generic | 35 | 37 | Under 11 | $1,101 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 31 | 31 | Under 11 | $4,355 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 31 | 31 | Under 11 | $143 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 28 | 36 | Under 11 | $134K |
| Cefepime Hcl Generic | 28 | 28 | Under 11 | $5,225 |
| Azithromycin Generic | 24 | 24 | Under 11 | $281 |
| Sodium Chloride 0.9 % Sodium Chloride | 23 | 23 | Under 11 | $1,606 |
| Cephalexin Generic | 22 | 30 | Under 11 | $463 |
| Amoxicillin Generic | 22 | 35 | Under 11 | $82.84 |
| Ertapenem Ertapenem Sodium | 21 | 21 | Under 11 | $12K |
| Rifabutin Generic | 21 | 29 | Under 11 | $17K |
| Cefadroxil Generic | 21 | 27 | Under 11 | $926 |
| Methenamine Hippurate Generic | 20 | 24 | Under 11 | $1,157 |
Brand drugs: 119 claims; generic drugs: 569 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin L Gnoni $57K ($57K in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $30K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 53 | $30K |
| Paratek Pharmaceuticals, Inc. | 29 | $17K |
| La Jolla Pharmaceutical Company | 12 | $6,423 |
| Shionogi Inc 4507.T | 8 | $1,518 |
| Gilead Sciences, Inc. GILD | 13 | $253 |
| Insmed, Inc. INSM | 10 | $177 |
| ViiV Healthcare Company GSK | 6 | $136 |
| Merck Sharp & Dohme LLC MRK | 5 | $110 |
| Melinta Therapeutics, LLC | 3 | $75.65 |
| Tetraphase Pharmaceuticals, Inc. | 3 | $68.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.